Last checked at 29 Apr 2010 12:44
BEXIMCO PHARMACEUTICALS LTD.
29th April, 2010
PRICE SENSITIVE INFORMATION
Beximco Pharmaceuticals Limited ("BPL" or "Company"; AIM Symbol: BXP) today announces information for Shareholders of the Company that the Board of Directors at their meeting held on 29th April, 2010 has decided the following:
| 1. To recommend the approval of the Financial Statements for the year ended 31 December 2009 | : | The results are expected to be announced week commencing Tuesday 4th May 2010 |
|
|
|
|
| 2. Date & Time of 34th AGM of the Company for the year 2009 | : | 15th June, 2010 at 10.00 a.m. |
|
|
|
|
| 3 Venue of AGM
| : | Beximco Industrial Park, Sarabo, Kashimpur, Gazipur, Bangladesh |
|
|
|
|
| 4. Proposed Dividend for year ended 31 December 2009 | : | 15% Stock dividend (i.e.15 shares for every 100 shares held) |
|
|
|
|
| 5. Record date | : | 19th May, 2010 |
|
|
|
|
| 6. Net Asset Value as at 31 December 2009 | : | Taka 10,885,706,614 |
|
|
|
|
| 7. Net Asset Value per share as at 31 December 2009 | : | Taka 72.02 |
|
|
|
|
| 8. Net Profit After Tax for the year ended 31 December 2009 | : | Taka 624,740,307 |
|
|
|
|
| 9. Earnings per share (EPS) for the year ended 31 December 2009 | : | Taka 4.13 |
|
|
|
|
| 10. Net Operating Cash Flow per share for the year ended 31 December 2009 | : | Taka 3.45 |
For further enquiries please contact:
Beximco Pharma
Nazmul Hassan, MP, Managing Director
Tel: +880 2 861 9151, ext.2080
Md. Asad Ullah, FCS, Company Secretary
Tel: 88028611891-5. Ext 1140
Libertas Capital
Jakob Kinde / Anthony Rowland
Tel: +44 (0)20 7569 9650
Financial Dynamics
Jonathan Birt / Susan Quigley
Tel: +44 (0)20 7269 7169
Notes to Editors
About Beximco Pharmaceuticals Limited
Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids. The Company also manufactures and markets its own branded generics for almost all diseases. The Company also undertakes contract manufacturing for multinational pharmaceutical companies. The Company operates from a 20 acre site in Dhaka and currently employs over 2,400 staff.
The Company's products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in East Africa, Pacific Island and Central American countries and South East Asia, including Singapore and Hong Kong.